The University of Missouri’s Orthopedic Institute has developed what they call the Mizzou BioJoint. Mizzou is aggressively marketing the BioJoint as a cutting edge, proven surgical procedure to address knee pain in patients younger than 50 years old. The Mizzou Biojoint is marketed as an alternative to traditional total or partial joint replacement surgery.
What is a “BioJoint.”
The Mizzou Biojoint is a registered trademark Mizzou surgeons use for procedures using large scale osteochondral allografts to address osteoarthritis and other causes of cartilage loss. These allografts are harvested from cadaver joints. Traditionally, smaller scale allograft plugs are used to repair focal area cartilage defects in the knee. However, the Mizzou BioJoint utilizes much larger allografts that involve removing and replacing half or more of the articular surfaces of the knee. Mizzou promotes these procedures as an alternative to traditional total joint replacements.
The question is, is it safe? Investigation to date reveals a number of serious concerns.
Is this a proven safe procedure?
While the marketing campaigns don’t divulge this, the physicians at Mizzou have only been doing these procedures for about 2 years, so there is NO long term data about the safety and success of these procedures.
Mizzou does not appear to have submitted the clinical results of these procedures to the scientific or medical community for peer review and validation.
Mizzou recently began disclosing to patients that some procedures are known to have up to a 60% failure rate.
Are these procedures part of a clinical study?
In August 2017, several years after Mizzou began performing BioJoint procedures, Mizzou registered a clinical study. The parameters of that study appear to encompass many of the procedures that Mizzou surgeons performed in 2015 and 2016.
Mizzou physicians have grants from the U.S. military to study these procedures.
Does the Mizzou BioJoint have a proven history of long term success?
Mizzou has only been performing the BioJoint procedures since approximately 2015. In the orthopedic field, researchers generally look at 5 and 10 year periods and longer to determine a procedures viability and efficacy.
Mizzou has arguably been researching in this area for an extended time, mainly in “canine models.” In fact, Mizzou’s lead researcher in the field is not a medical doctor but rather a veterinarian. There have been no long term human studies.
If you are considering a BioJoint procedure, please proceed carefully. Get the facts before committing to this procedure.
If you have had a BioJoint procedure and have experienced any of the following, you should consider legal action:
• Multiple reoperations
• Allograft failure
• Conversion to a traditional total joint replacement
• Limited range of motion
• Continuing pain
HendricksonLaw is actively investigating cases involving failures, infections, re-operation and other issues involving the Mizzou BioJoint.
If you have questions, please contact us immediately. You have a limited time to file any legal action involving the BioJoint procedure.
Mizzou BioJoint is a registered trademark of the University of Missouri.